Global Cell-Based Assays Market Is Set to Increase About $26.5 Billion By 2030

The global cell-based assays industry size was nearly $16.3 Billion in 2022 and is set to increase to about $26.5 Billion by 2030 along with securing the highest gains of 12.4% from 2023 to 2030.

Cell-based assays assist in monitoring the effectiveness of compounds in a cellular environment. This, in turn, is key in understanding compound behaviors in a biological ecosystem and bringing into line data with a translatable biomarker. Cellular assays are finding a plethora of applications in biomedical and drug-discovery testing activities.

This will help in effectively determining toxicity, biological activities, biochemical equipment, and off-target interactions. The advantage of making utilization of cell-based assays are the generation of complicated and biologically relevant data. Unlike conventional biochemical assays, cell-based assays are physiologically relevant and can determine complicated properties simultaneously.

Pharma & biotech companies and CROs are making utility of cell-based assays for detecting and optimizing methods in drug discovery methods. This, in turn, will help in carving a favorable growth curve for the cell-based assays market across the globe. The manufacturing price of biopharmaceuticals has increased to a major extent and hence healthcare professional including hospitals & clinics are likely to adopt the use of cell-based assays. This will prompt the expansion of the global market trends.

Nevertheless, huge device costs and low usage of reagents can hinder the global cell-based assays industry expansion in the forecasting years. In addition to this, massive costs of maintaining equipment used in biotech research and an increase in indirect spending as well as a surge in the overall costs of ownership of devices can further decimate the industry growth across the globe. Increase in the investments for research & development activities related to biotech & pharma sectors will open new facets of growth for the global industry.

The global cell-based assays market is divided into application, product, end-use, and region.                

The application segment of the cell-based assays market is segmented into reagents, cell lines, instrument & software, assay kits, microplate, and services segments. Moreover, the assay kits segment, which led the application space in 2022, is set to maintain its segmental dominance even in the foreseeable future. The segmental expansion in the coming years can be owing to its large-scale use in the biopharmaceutical industry.

On the basis of product, the cell-based assays industry across the globe is bifurcated into basic research and drug discovery segments. The drug discovery segment, which led the application landscape in 2022, is projected to contribute to a major industry share in the forecasting years. The upsurge of the segment in the next couple of years can be subject to the strong demand for new therapeutic drugs including generic ones for effective treatment of a spectrum of ailments across the globe. The scaling up of the drug discovery segment can be due to a prominent increment in the number of FDA approvals of newly launched drugs which also include generic drugs.

Based on the end-use, cell-based assays across the globe is sectored into academic & research institutes, pharmaceutical & biotech companies, and CROs segments. Moreover, the academic & research institutes segment, which contributed lucratively towards the global market share in 2022, is anticipated to register the highest CAGR over the next eight years. The expansion of the segment in the next couple of years can be ascribed to an increase in the acceptance of these cell-based assays in biotech research & development ventures as well as the devising of new assay-based diagnostics. Apart from this, Moreover, cell-based assays assist in research in the oncology, stem cells, and immunology domains.

In addition to this, North America, which contributed to more than two-fifths of the global cell-based assays market share in 2022, is expected to establish a number one position in the global market over the estimated timeline. The regional market upsurge from 2023 to 2030 can be owing to extensive research on medical products in the U.S. and Canada. Apparently, the presence of well-known academic research organizations as well as pharmaceutical industries in North America will account sizably for the regional market size.

Browse the full “Cell-Based Assays Market By Product & Service (Reagents, Cell Lines, Instrument & Software, Assay Kits, Microplate, and Services), By Application (Basic Research and Drug Discovery), By End-Use (Pharmaceutical & Biotech Companies, Academic & Research Institutes, and CROs), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 – 2030.” Report at https://www.zionmarketresearch.com/report/cell-based-assays-market

Recent Developments:

• In the second quarter of 2020, PhenoVista Biosciences, a U.S.-based CRO firm in the in-vitro cell-based assays sector, entered into a strategic collaboration with Olympus Corporation, a Japanese firm manufacturing reprography & optics items, for providing 3D cell-based assay services for drug discovery procedures. The strategic move is predicted to spur the expansion of the cell-based assays market globally.
• In the second half of 2022, Life Net Health Lifesciences, a key organization offering new human cell & tissue-based solutions for biomedical research to develop next-gen treatments, launched cell-based assays including biocompatibility assays and cytotoxicity screening tests. The move will contribute lucratively towards the growth of the cell-based assays industry proceeds in the years ahead.
• In the first half of 2022, Beckman Coulter Life Sciences, a major Danaher company highlighting providing healthcare services, launched the Aquios STEM system which provides a new solution for stem cell research. The initiative is likely to benefit the cell-based assays market growth across the globe in the upcoming years.

Key players in the global cell-based assays market include:

• Charles River Laboratories
• F. Hoffmann-La Roche Ltd. (Roche Holdings AG)
• BD
• Promega Corp.
• Merck KGaA
• Corning Inc.
• Bio-Rad Laboratories Inc.
• Lonza AG
• Danaher Corp.

The global cell-based assays market is segmented as follows:

By Product & Service

• Reagents
• Cell Lines
• Instrument & Software
• Assay Kits
• Microplate
• Services

By Application

• Basic Research
• Drug Discovery

By End-Use

• Pharmaceutical & Biotech Companies
•  Academic & Research Institutes
• CROs

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com